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Spectrum of mutations in the MECP2
gene in patients with infantile autism
and Rett syndrome
EDITOR—Rett syndrome (RTT, MIM 312750) is a
progressive neurological disorder, occurring almost exclu-
sively in females during their first two years of life . RTT is
one of the most common causes of mental retardation in
females, with an incidence of 1 in 10 000-15 000 female
births. Patients with classical RTT appear to develop nor-
mally until 6-18 months of age, then gradually lose speech
and purposeful hand use, and, eventually, develop
microcephaly, seizures, autism, ataxia, hyperventilation,
and stereotypic hand movements. After the initial
regression, the clinical condition stabilises and patients
usually survive into adulthood. Laboratory investigations
have not shown any metabolic abnormalities in aVected
subjects.1 RTT is included in the diVerential diagnosis of
autistic disorder in girls.1–3 Qualitative abnormalities in
social and communicative development and stereotypic
behaviour are typically present in RTT. Definitive diagno-
sis is often delayed until after the loss of purposeful hand
movements and the relatively characteristic hyperventila-
tion later in childhood,1 and earlier diagnosis would be
desirable.
The occurrence of a few familial cases with maternal
inheritance suggests that RTT is an X linked dominant
mutation with lethality in hemizygous males. Previous
exclusion mapping studies using RTT families identified a
locus in Xq28.4–6 Using a systematic gene screening
approach, Amir et al7 and Wan et al8 have identified muta-
tions in the MECP2 gene, which encodes methyl-CpG
binding protein 2, as the cause of some RTT cases. Most of
the mutations are de novo and occur at a CpG
dinucleotide. The cytosine in the CpG dinucleotide is a
frequent site for DNA methylation and deamination of
methylated cytosine to thymine causes the transition.
The MeCP2 protein silences methylated chromatin by
recruiting a histone deacetylase complex.9 Unlike most
other transcriptional repressor proteins, however, the
binding site of MeCP2 occurs frequently in genomic DNA
as it requires only a single methylated CpG base pair to
bind. MeCP2 contains two functional domains, an 85
amino acid methyl-CpG binding domain (MBD) (residues
78-162), essential for its binding to 5-methylcytosine, and
a 104 amino acid transcriptional repressor domain (TRD)
(residues 207-310) that interacts with histone deacetylase
and the transcription corepressor Sin3. It has been shown
that interactions between this transcription repressor com-
plex and chromatin bound MeCP2 leads to deacetylation
of core histones, which in turn leads to changes in chroma-
tin architecture and transcriptional repression.
To date, the mutational spectrum of MECP2 in Chinese
is not known. To define the role of MECP2 mutations
causing RTT in our population, we have screened MECP2
mutations by denaturing high performance liquid chroma-
tography (DHPLC). As RTT is included in the diVerential
diagnosis of autistic disorders in girls, we have also
screened MECP2 mutations in a group of female patients
with autism and mental retardation.
We screened genomic DNA from 13 sporadic RTT
patients and 21 patients with autism and mental
retardation by DHPLC and by direct DNA sequencing. All
the subjects were unrelated females and were ethnic
Chinese, with no family history of the disease. The clinical
findings met the criteria of inclusion and exclusion for the
diagnosis of RTT.10 Patients with autism and mental retar-
dation were obtained from a previous study.11 The diagno-
sis of autism was based on clinical features and evaluated
by diagnostic criteria from DSM-IV.12 Most of them had
onset of autistic features at less than 3 years of age.
Informed consent was obtained from the patients or the
parents.
Genomic DNA was extracted from peripheral blood
samples using a QIAamp Blood Kit (Qiagen) according to
the manufacturer’s instructions. PCR amplification was
conducted using primer pairs and conditions described
elsewhere.7 8 PCR products were purified by MicroSpin
columns S-300 (Pharmacia Biotech) according to the
manufacturer’s instructions. PCR products shorter than
those expected from the wild type sequence (in patients
PWH24 and PMH65) were extracted from agarose gels
using QIAquick Gel Extraction kit (Qiagen) according to
the manufacturer’s instructions. Direct sequencing of the
PCR products was performed using the ABI PRISM
dRhodamine Terminator Cycle Sequencing Ready Reac-
tion Mix (PE Biosystems). Sequencing fragments were
separated by capillary electrophoresis and detected via
laser induced fluorescence on an ABI PRISM 310 Genetic
Analyzer (PE Biosystems). Both strands were sequenced to
confirm all the mutations detected. Sequencing results
were compared with the reference human MECP2
sequence (GenBank X99686).
Heteroduplex analysis was performed on a WAVE™
DHPLC instrument (Transgenomic). Analysis was per-
formed at a temperature suYcient to partially denature
(melt) the DNA heteroduplexes. The melted heterodu-
plexes are resolved from the corresponding homoduplexes
by ion pair reversed phase liquid chromatography. The
procedure is referred to as temperature modulated
heteroduplex chromatography (TMHC). THMC relies
upon the physical changes in DNA molecules induced by
mismatched heteroduplex formation during reannealing of
wild type and mutant DNA. Between 5 and 10 µl of crude
PCR product was loaded on a DNASep column (Trans-
genomic) and was eluted from the column by an acetonitrile
gradient in a 0.1 mol/l triethylammonium acetate (TEAA)
buVer, pH 7.0, at a constant flow rate of 0.9 ml/minute.
The standard buVers are prepared from concentrated
TEAA to give A=0.1 mol/l TEAA, B=0.1 mol/l TEAA, and
25% acetonitrile. The gradient was created by mixing elu-
ents A and B. The recommended gradient for mutation
detection is a slope of 2% increase in buVer B per minute.
Eluted DNA fragments were detected with ultraviolet
absorption at wave length 260 nm. The WAVE utility soft-
ware helps to determine the correct temperature for muta-
tion scanning based on the sequence of the wild type DNA.
We used a methylation specific PCR assay developed at
the human androgen receptor locus (HUMARA) on the X
chromosome for X inactivation studies. The X inactivation
pattern is defined as the ratio of the corrected peak area of
a smaller allele to the corrected peak area of a larger allele.13
Among the 13 RTT patients, we identified one missense
mutation, two nonsense mutations, one microdeletion, and
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two insertion/deletions (indels). Three of the mutations
were novel (fig 1) and three of the mutations have
previously been reported.7 8 14 All are de novo mutations.
None of these mutations were detected in 200 normal X
chromosomes. Four of the six patients with MECP2 muta-
tions were heterozygous for the androgen receptor gene
polymorphism and the XCI results are shown in table 1.
One missense mutation was detected. The mutation,
390C→T, is located in exon 2 and changes codon 106 from
CGG to TGG. This mutation occurs at a CpG
dinucleotide and changes the coded amino acid residue
from arginine to tryptophan, that is, R106W, in patient
CG1295. 390C→T, leading to the R106W substitution in
the MBD, was previously found in aVected half sisters but
not in their common mother7 and in an unrelated sporadic
case.8 The substituted arginine residue is conserved in
MeCP2 from mammals to Xenopus laevis.7
The two nonsense mutations, which also occur at a CpG
dinucleotide, that is, 576C→T (R168X) and 954 C→T
(R294X) in patients CMC52 and PWH23, respectively,
are located in exon 3. The 576C→T mutation changes
codon 168 from CGA to TGA, changing the arginine
codon to a stop codon. This mutation was found previously
in five unrelated white subjects, one Japanese, and a Brazil-
ian family with three aVected sisters.7 8 Our results
confirmed that R168X is a frequent mutation causing
RTT. Codon 168 is located between the MBD and the
TRD. The putative truncated protein of 167 amino acids,
lacking the nuclear localisation signal (NLS) within the
TRD, is predicted to be located predominantly in the cyto-
plasm. The nonsense mutation in patient PWH23 is a
C→T transition at nucleotide position 954, which converts
a CGA to a TGA (R294X) that predicts truncation of the
MeCP2 protein at residue 294 of 486. This mutation is
located in the TRD. The truncated protein may cause
abnormal folding or aVect interactions with other proteins
of the Sin3A/histone deacetylase silencing complex.
The indel in patient PWH44, 824delCins11, is located in
the TRD. The mutation involves a deletion of the last nucle-
otide at codon 250 followed by insertion of an 11 bp
sequence, that is, 5'-TCAGGAAGCTT-3' and causes a shift
of the reading frame. This shift creates a stop codon TGA at
codon 261, that is, P261X. A truncated protein of 260 amino
acids results and the TRD domain is disrupted. The indel in
patient PWH24 is 1118del131insTG. This indel starts at
codon 348, changing the codon from GAG to GTG. This
changes the amino acid at position 348 from glutamic acid to
valine, that is, E348V, but does not change the reading
frame. Forty three codons, from codons 349 to 391, are
deleted, that is, S349-P391del43,15 leaving the C-terminal of
the protein from amino acid residues 392 to 486 intact.
However, this deletion eliminates both the poly-His and
poly-Pro domains and a truncated protein of 443 amino
acids results. The microdeletion, 1231del41, in patient
PMH65, involves a deletion of 41 bases starting from the
second nucleotide of codon 386 to the last nucleotide of
codon 399. This mutation causes the deletion of the
poly-Pro domain (codons 384 to 393). The deleted region is
flanked by a direct repeat of four cytosine bases. This small
deletion may be caused by replication slippage errors result-
ing from looping out of the template strand during DNA
replication. This mutation shifts the reading frame at codon
386 and creates a stop codon TGA at codon 389. A
truncated protein of 388 amino acids, P389X, results.
We identified three novel MECP2 polymorphisms in the
sequence analysis of the RTT and autistic patients. The
single nucleotide polymorphism (SNP) IVS2+22C→G in
patients CMC51 and PWH55 was located in intron 2 (data
not shown). We found this SNP in normal males, indicat-
ing that IVS2+22C→G is a neutral polymorphism.
Another SNP, 676C→T, changes codon 201 from GCG to
GTG in patient QMH58, changing the amino acid from
alanine to valine, that is, A201V (data not shown). The
SNP is de novo as it is not found in either parent. The
Figure 1 Analysis of the MECP2 gene. DNA sequence analysis of the four novel mutations found in patients PMH65 (A), PWH44 (B), PWH24 (C),
and PWHA34 (D). Arrows in (A) and (C) indicate the deletion breakpoints. The 5' splice site of intron 2 is underlined in (D). The arrows in (B)
indicate the positions of the sequence, 5'-TTT-3', in the sequences of the wild type and mutant alleles. The DNA sequences of (A) and (D) are shown in the
sense direction. The DNA sequences of (B) and (C) are shown in the antisense direction.
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amino acid is not conserved and the SNP has been found
in normal males, indicating that 676C→T is a neutral
polymorphism. In patient PWHA5, we found a SNP
changing the ninth base of the 3'-UTR from G to A (data
not shown). However, this nucleotide is not conserved and
the nucleotide at the analogous position in mouse is
adenine. This SNP represents a rare polymorphism.
In one of the patients with infantile autism, PWHA34, we
found a mutation, IVS2+2delTAAG, in the 5' splicing site of
intron 2, causing a deletion of four bases TAAG from the
second base of the intron. This mutation was not found in
her parents or 200 normal X chromosomes. The mutation
was probably caused by mispairing of a direct repeat of
5'-taag-3' in the sequence 5'-gtaagTaaggagcaactcctatct-3'.
The mutation retains a GT dinucleotide, that is, 5'-
gTaaggagcaactcctatct-3', but the sequence of the splicing site
will change from IVS+6 position onwards. Using SpliceView
(http://www.itba.mi.cnr.it/webgene/), the mutant splice site
has a lower consensus value (score 82) than the wild type
splice site (score 84). Two downstream splice sites which
have higher consensus values (IVS+77 with a score of 83 and
IVS+131 with a score of 84) may act as the new 5' splice sites
(table 2). This is predicted to cause aberrant splicing with
partial intron 2 retention and premature termination.
Unfortunately, mRNA was not available to evaluate the pre-
dicted result.
We found six MECP2 mutations in 13 patients with
classical RTT. Four of the six mutations (R168X, P261X,
R294X, P389X) lead to premature termination of transla-
tion. The 1118del131insTG mutation leads to a truncated
protein of 443 amino acids [E348V;S349-P391del43].
Three patients with MECP2 mutations have moderately
skewed XCI patterns. This is consistent with the fact that
RTT patients as a group have a higher frequency of mod-
erate skewing (65-80%) of XCI in lymphocytes, when
compared with normal controls.16 Like previous studies, we
found that several (three out of six) of the mutations caus-
ing RTT are C→T transitions occurring at CpG
dinucleotides. These mutations are probably the result of
methylation deamination of the CpG dinucleotide. In
addition, we found several direct repeats from codon 350
to 411. Within these 186 nucleotides, there are five simple
direct repeats of four cytosine bases, two simple direct
repeats of five cytosine bases, and two simple direct repeats
of six cytosine bases. In addition, there are two direct
repeats of three AGC and two direct repeats of three CAC.
Together, there are 78 nucleotides located in a direct repeat
sequence, accounting for about 42% of the sequence (fig
2). This part of the gene might be more vulnerable to rear-
rangement mutations.
The MeCP2 protein has one poly-Ala domain (residues
277 to 283: (5×Ala)-Glu-Ala), one poly-His domain (resi-
dues 366 to 372: 7×His), and one poly-Pro domain
(residues 384 to 393: Pro-Pro-Leu-(5×Pro)-Glu-Pro).
Although the functions of these three domains in the pro-
tein are unclear, they are all evolutionarily conserved from
mammals to Xenopus laevis. We found two mutations that
disrupt one or two of these domains. Interestingly, the
mutation in patient PWH24 disrupts both the poly-His
and poly-Pro domains without altering the reading frameTa
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Table 2 SpliceView analysis of the donor splice junction of intron 2 of the
MECP2 gene
Donor splice junction Exon sequence Intron sequence Score
IVS2+1 CAA GTAAGT 84
IVS2+5 TAA GTAAGA 81
IVS2+77 AAT GTATGT 83
IVS+131 CAG GTGTGC 84
IVS+1 (mutant) CAA GTAAGA 82
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and the rest of the C-terminal. Together, these results sug-
gest that these domains are important for the normal func-
tion of the protein and that disruption of these domains
might alter the conformation of the protein.
We identified a mutation in one of the 21 patients with
infantile autism. The mutation involved the 5' splice site of
intron 2. The aVected patient, PWHA34, presented to us at
4 years of age with a mental age close to 2 years and
significant diYculties in social interaction and communica-
tion. Her spoken language has not developed, but she did
not show a regression phase in her clinical course. There is
no evidence of seizures, kyphoscoliosis, stereotypic hand
movements, or microcephaly. Unfortunately, we are unable
to re-evaluate the clinical diagnosis because the patient has
already been lost to follow up. Further investigations will be
required to determine whether this mutation interferes
with gene product function.
To date, only three MECP2 mutations have been identi-
fied in 17 RTT families.7 8 14 Thus, 14 RTT families do not
have mutations in either the coding region or the
intron/exon boundaries of MECP2 to account for the dis-
order. The presence of abnormalities in the untranslated
regions of the MECP2 mRNA and genetic regulatory ele-
ments have yet to be explored, but it is also possible that
another tightly linked locus may be present on chromo-
some Xq28. Until now, the diagnosis of RTT has relied
solely on clinical observations. The discovery of MECP2 as
an RTT associated gene will enable the development of a
test for earlier diagnosis using DNA based methods. Muta-
tional analysis at the DNA level will increasingly contribute
to diagnosis of RTT, particularly in atypical cases.
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Figure 2 Simple direct repeats in exon 3 of the MECP2 gene. The direct repeat sequences
are shown in bold. The poly-His and poly-Pro domains are underlined.
AGC AAG GAG AGC AGC CCC AAG GGG CGC AGC AGC AGC GCC TCC TCA
Ser346
360
Ser Ser Ser Ser SerSer Ser AlaProLys LysGlu Gly Arg
CCC CCC AAG AAG GAG CAC CAC CAC CAT CAC CAC CAC TCA GAG TCC
361
375
SerHisHis His His His His His SerPro Pro Lys Lys GluGlu
CCA AAG GCC CCC GTG CCA CTG CTC CCA CCC CTG CCC CCA CCT CCA
376
390
Leu Leu LeuAlaPro Pro ProPro Pro ProProProProLys Val
CCT GAG CCC GAG AGC TCC GAG GAC CCC ACC AGC CCC CCT GAG CCC
391
405
Ser Ser Thr SerPro Pro Pro Pro Pro ProGlu Glu Glu GluAsp
CAG GAC TTG AGC AGC AGC GTC TGC AAA GAG GAG AAG ATG CCC AGA
Gln Asp Leu Ser Ser Ser Val Cys Lys Lys Met Pro ArgGlu Glu406
420
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